Page last updated: 2024-08-23

ethylketocyclazocine and paclitaxel

ethylketocyclazocine has been researched along with paclitaxel in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakogeorgou, E; Castanas, E; Hatzoglou, A	1

Other Studies

1 other study(ies) available for ethylketocyclazocine and paclitaxel

Article	Year
Taxol inhibits opioid binding on T47D human breast cancer cells. Biochemical and biophysical research communications, 1997, Jun-09, Volume: 235, Issue:1 Topics: Amino Acid Sequence; Analgesics, Opioid; Antineoplastic Agents, Phytogenic; Binding Sites; Binding, Competitive; Breast Neoplasms; Diprenorphine; Ethylketocyclazocine; Humans; Molecular Sequence Data; Paclitaxel; Receptors, Opioid; Receptors, Opioid, kappa; Sequence Alignment; Tubulin; Tumor Cells, Cultured	1997

Article

Year

Taxol inhibits opioid binding on T47D human breast cancer cells.

Biochemical and biophysical research communications, 1997, Jun-09, Volume: 235, Issue:1

Topics: Amino Acid Sequence; Analgesics, Opioid; Antineoplastic Agents, Phytogenic; Binding Sites; Binding, Competitive; Breast Neoplasms; Diprenorphine; Ethylketocyclazocine; Humans; Molecular Sequence Data; Paclitaxel; Receptors, Opioid; Receptors, Opioid, kappa; Sequence Alignment; Tubulin; Tumor Cells, Cultured

1997